Elon Musk-led brain implant developer Neuralink has raised $39.3 million in a new round of equity financing, according to a recently posted SEC filing.
Neuralink aims to create “neural lace” technology, which uses tiny connected brain implants to use intractable brain disease and improve cognitive performance.
The company is still in its early phases and has not yet publicly stated its goals outside “ultra high bandwidth brain-machine interfaces to connect humans and computers,” according to its website.
Funds in the round came from seven unnamed investors, with the first date in the sale noted as having occurred on April 26.
The company is looking to raise an additional $12 million in the round, which would bring the total raised up to approximately $51.3 million, according to the SEC filing.
The company came to light in 2017 in a Wall Street Journal report.